The fitness cost of antibiotic resistance in the absence of antibiotics is crucial to the 11 success of suspending antibiotics as a strategy to lower resistance. Here we show that 12 after antibiotic treatment the cost of resistance within the complex ecosystem of the 13 mammalian gut is personalized. Using mice as an in vivo model, we find that the 14 fitness effect of the same resistant mutation can be deleterious in a host, but neutral or 15 even beneficial in other hosts. Such antagonistic pleiotropy is shaped by the 16 microbiota, as in germ-free mice resistance is consistently costly across all hosts. An 17 eco-evolutionary model of competition for resources identifies a general mechanism 18 underlying between host variation and predicts that the dynamics of compensatory 19 evolution of resistant bacteria should be host specific, a prediction that was supported 20 by experimental evolution in vivo. The microbiome of each human is close to unique 21 and our results suggest that the short-term costs of resistance and its long-term within-22 host evolution will also be highly personalized, a finding that may contribute to the 23 observed variable outcome of control therapies. 24 25 few studies where pathogens 25-31 were tested during in vivo colonization and infection 51
INTRODUCTION 26
Antibiotic resistance (AR) is a growing challenge in the treatment of infectious 27 diseases which are projected to become a burden worldwide in the coming decades 1 . 28
The set of AR genes and AR mutations -called resistomes -is widespread in 29 clinical 2,3 and environmental 4,5 settings, providing a reservoir that can further expand 30 by horizontal gene transfer. Commensal bacteria can carry AR in healthy individuals 31 and AR can persist in the human gut for years 6 . 32
Chromosomal encoded resistance mutations often map onto genes coding for essential 33 cellular functions, such as transcription, translation, or cell-wall biogenesis (see 34 e.g. 7, 8 ). Resistance tends to be highly epistatic and pleiotropic 9-11 and typically entails 35 fitness costs in the absence of antibiotics [12] [13] [14] [15] . The existence of AR costs predicts that 36 a susceptible strain should out-compete a resistant strain, and a decrease of resistance 37 levels to a given antibiotic should occur if the use of that drug is halted in clinical 38 settings. This strategy should be effective when the cost of resistance is high [16] [17] [18] [19] , 39
allowing for the elimination of the AR strain before evolutionary compensation for 40 the cost of resistance occurs 8 . Thus, the efficacy of controlling the spread of AR by 41 suspending the usage of an antibiotic is critically dependent on the relative fitness of 42 resistant and sensitive genotypes in the absence of antibiotic. 43
The costs of AR are strongly influenced by the environment where bacteria grow, 44 both in its abiotic (e.g. nutrient availability) and biotic (interactions with other cells) 45 components [20] [21] [22] . Fitness costs of AR can also depend on the genetic background, 46
including the presence of other resistances, at the level of the core and accessory 47 genome 9,23,24 . Since the effects of AR mutations have often been measured under 48 laboratory environments, which lack the multiple interactions likely to be important in 49 natura, our understanding of how costly AR can actually be is currently limited. A 50 4 external strains occurs. To measure the in vivo fitness effects of AR and quantify their 76 costs, which should occur in the absence of antibiotic, we removed the treatment for 77 two days and then colonized the mice with susceptible and resistant E. coli strains 78 ( Fig. 1a) . Previous studies suggest that streptomycin is quickly removed from mice 36 79 and we have experimentally confirmed that streptomycin is absent 2 days after 80 treatment is stopped, via a biological detection method in the fecal samples (the 81 developed method has a threshold of detection of ≈2µg/ml) ( Supplementary Fig. 1) . 82
In agreement, we see variation of costs even when the competition is between two 83 strains that are resistant to the streptomycin (Supplementary Fig. 2) . 84
For most of the competitions, the temporal dynamics of each of the resistant strains in 85 each mouse, and hence, the fitness effects of AR within a host, were consistent with a 86 constant selective effect throughout 5 days of colonization ( Fig. 1b) . However, a wide 87 variation in the temporal dynamics of Log (AR/Susceptible) is observed between each 88 mouse ( Fig. 1b) . Such variation is not the result of sampling noise but unveils host-89 specific fitness effects of AR. Remarkably AR caused a strong deleterious effect in a 90 particular host, whereas in another host AR did not exhibit a significant cost ( Fig. 1b  91 and Supplementary Table 1 ). These results strongly suggest that the elimination of 92 AR will likely take a very long time to occur, or may not occur at all, in certain hosts. 93
Frequency dependent selection is unlikely to be the cause of the observed temporal 94 variation in the frequency of AR between hosts, as the initial frequency of the 95 resistant strain is not predictive of the resistance fate (Fig. 1b) . The occurrence of 96 compensatory mutations, although possible, is also unlikely to explain the observed 97 variation. Such events would have to be very common and also entail strong 98 beneficial effects to influence the estimated fitness difference within the 5 day period 99 studied. Compensatory mutations are also expected to take longer periods to be rise in 100 5 frequency (see below) and their spread should lead to strong temporal variations in 101 the frequency of AR strains within each mouse, causing significant deviations from a 102 simple linear model, a pattern which was not observed. The data strongly suggests 103 that constant selection against resistance occurs in a host, but selection for resistance 104 can occur in another host during the 5-day co-colonization period. Such observation 105 cannot be explained by the occurrence of back-mutations or by mutations that would 106 render the bacteria sensitive to the antibiotic ( Supplementary Table 2 ). 107
To investigate if the presence of a complex microbiota is an important contributor to 108 the personalized fitness of AR, we performed co-colonization experiments in germ-109 free mice. Here the in vivo fitness costs of AR are solely derived from intra-strain 110 competition in the gut and we find much lower variance between these hosts. 111
Significant fitness costs of each resistant strain were estimated in this in vivo but 112 simpler environment: S Str R /day = -0.20 (± 0.09, 2*SE), S Rif R /day = -0.25 (±0.08) and 113 S Str R Rif R /day = -0.44 (± 0.10) ( Fig. 1c and Supplementary Table 3 -4, corresponding to 114 1 to 2% cost per generation 37 , implying that AR should be eliminated within 50 to 100 115 generations, in the absence of antibiotics. The fitness effects of AR estimated in vivo 116 are significantly different from those estimated in vitro (Supplementary Fig. 3) . 117
Indeed none of the commonly used laboratory environments provides a good 118 predictor to the costs of single AR mutations, in the simplest in vivo system lacking a 119 complex microbiota, nor of their combined effects (see Supplemental Text and 120
Supplemental Fig. 3). 121
Having found that the fitness effects of AR are host-specific, we next asked about 122 their effects at the population level. Taking the cohort of mice studied as a population, 123
we find that AR is costly on average ( Fig. 1d) Characterization of the gut microbiota composition of the cohorts of mice, through 128 16S rRNA sequencing, showed that antibiotic treatment both reduced the alpha 129 diversity (p<0.001) and increased substantially the variation of the host microbiota 130 ( Fig. 1e-f) . These results suggest that the personalized fitness effect of AR likely 131 results from an interaction between the effect of AR and the microbial gut ecosystem. 132 133
Modeling AR costs within a species rich ecosystem 134
To understand whether general properties of the microbiota could cause host-specific 135 effects of mutations we turned to a theoretical model. If most prevalent interactions in 136 the microbiota are competitive, as suggested by previous analysis 38 , we can use the 137
MacArthur consumer-resource model, which only assumes competition. This 138 framework is capable of explaining major diversity patterns of microbial 139 communities 39 . The model was adapted to quantify the effect of a diverse microbiota 140 on the relative fitness of an AR mutation (which is costly in the absence of other 141 species) both analytically and numerically. This theoretical framework seems 142 appropriate since the resistances studied affect core genes in bacterial metabolism and 143 alter growth rates in different carbon sources ( Supplementary Fig. 4 ). We assume 144 that bacteria compete for a set of non-essential resources ! , … , ! and each species is 145 defined by their resource consumption rates α in a -dimensional phenotypic space 146 ( Fig. 2a-b) . We start by assuming that the species of the microbiota ( ) initially 147 satisfy the conditions for stable coexistence (Supplementary Text, eq.3). To quantify 148 the fitness effect in this context, we assume that a mutant has a phenotypic difference 7 from its parental wild type (α !"# = α !" + Δ) such that its overall fitness is impaired 150 relative to the total amount of resources that the parent could consume (
The selection coefficient in the presence of other species is then given by: 152
being the concentration of species . The 153 phenotypes modeled here can be thought of as enzymes dynamics, e j (t), as they 154
represent key functional units likely to be relevant in the competitive environment. 155
Their abundance in the ecosystem (which is proportional to the density of the species) 156 can vary over time, especially in the context of a strong perturbation, such as the 157 antibiotic treatment in our experimental system. From the time-dependent form of 158 selection in (eq. 1) one can deduce the following results: Firstly, at equilibrium 159 ( ! = ! ∀ ), selection on the traits is additive, constant and independent of the 160 microbiota composition (Supplementary Text, eq.7). However, the presence of a 161 stable microbiota can amplify or buffer the cost of a mutation, according to its 162 specific effect ( Fig. 2c , Supplementary Text, eq.8). Furthermore, the probability that 163 the cost is buffered increases with the ratio between the traits ( Fig. 2d,  164 Supplementary Text, eq.8-9). Secondly, when the microbiota ecosystem is pushed 165 out of equilibrium via a perturbation (e.g. antibiotic treatment), the fate of a 166 previously deleterious mutation can be significantly altered. Under such conditions, 167 selection on the mutant becomes host-specific and can be negative, neutral or even 168 positive in the short-term (Supplementary Text, eq.10-11). 169
We performed numerical simulations (see (eq. 1) depends on the specific mutant (see Fig. 3 ). If a mutation changes two traits but not 173 their ratio, its fitness cost is independent of the microbiota composition ( Fig. 3a-b , 174 Mutant x). For a mutation that causes an increase on one trait but a decrease on the 175 other, the functional content of the ecosystem determines which trait is beneficial or 176 detrimental and consequently, determines if the mutant is selected for or against (Fig.  177 3a-b, Mutants y and z have opposite fitness effects). Thus the model predicts variable 178 fitness effects across hosts and reveals how a pleiotropy-dependent mechanism 179 characteristic of AR mutants, can lead to their increase in frequency in the absence of 180 antibiotics (Supplementary Text, eq.11). Importantly, at longer time scales, as the 181 whole microbial ecosystem approaches equilibrium, the fitness effects converge 182 towards a negative value ( Fig. 3c) , which will eventually become constant across all 183 individuals (Supplementary Text, eq.7). These results indicate that an AR mutation, 184 which affects competition for resources, should exhibit a host-specific fitness effect 185 during the initial days of competition ( Fig. 1b) , and predict that the AR cost should 186 become host-independent once the microbiota reach equilibrium within a host. 
Compensatory evolution of AR strains 194
To experimentally test the theoretical prediction of time dependent compensatory 195 evolution, we followed the long-term evolutionary dynamics of each AR clone 196 colonizing the gut, after streptomycin treatment. Since the gut microbiota composition 9 is more similar in mice from the same litter than mice from different litters 40,41 , our 198 colonization experiment follows a design where the same AR background colonizes 199 two mice from different parents ( Fig. 4A) . Thus, each mouse will likely differ in its 200 microbiota composition state after antibiotic treatment is stopped (Fig. 4b) . Analysis 201 of the 16S rDNA in each colonized mouse indeed confirmed this expectation and 202 significant differences between mice were found ( Fig. 4b) . 203 We next queried about the evolutionary dynamics of compensatory mutations along 204 time and between hosts. To identify bona fide compensatory mutations we leveraged 205 on the fact that these AR mutations have been extensively studied in vitro, in different 206 media and bacterial species, and many of their targets have been identified 31,42-44 . 207
Adaptive mutations unrelated to AR can also occur in the mouse gut at the time scale 208 of weeks 35,45 and many of those can be similar between mice with different 209 microbiota compositions 37 . We thus expect adaptive mutations to be more similar 210 across mice than compensatory mutations, which ought to be more specific to the AR 211 background of the colonizing E. coli. Whole genome sequencing of pools of clones 212 around week 3 and 6 after colonization reveal a temporal signal of compensatory 213 evolution, and variation in the number of compensatory mutations between hosts. In 214 the first cohort of mice at least one compensatory mutation could be detected in all 215 AR backgrounds by the 3 rd week, whereas in the other cohort of mice no 216 compensation for Rif R or Srt R Rif R could be detected at this earlier time point ( Fig.  217   4c) . This result is consistent with the expectation that after antibiotic perturbation, 218 different microbiota compositions will reach equilibrium at different times and thus 219 selection for the spread of compensatory mutations will be time dependent. Consistent 220 with this interpretation, by the 6 th week the number of compensatory mutations 221 detected increased in three out of the six studied mice. Remarkably no signal of 222 compensatory evolution could be detected in one of the mice from cohort 2, even 223 though 11 adaptive mutations raised in frequency in the double resistant lineage that 224 colonized this host after six weeks of colonization ( Fig. 4d-e Table 5 ). This data indicates that the cost of double resistance can take a long time to 226 be expressed in specific hosts. 227
and Supplemental 225
Analysis of the targets of evolutionary change and their frequency with the colonizing 228 lineages showed that, in the majority of mice, adaptive mutations were more frequent 229 than compensatory mutations, irrespective of the host or the AR genetic background 230 ( Fig. 4d) . Overall 17 genes and 10 intergenic regions were called by natural selection 231 for global adaptation across the 6 studied mice. Some of these have been shown to be 232
adaptive when E. coli colonizes the gut of streptomycin-treated mice 35, [45] [46] [47] . 233
The temporal pattern of population genomic variation strongly suggests that clonal 234 interference between adaptive and compensatory mutations occurs. In some hosts the 235 emerging compensatory mutations had weaker benefits than other adaptive mutations 236 (e.g. mutations in fimE and tdcA reached higher frequencies than compensatory 237 mutations to either Str R or Rif R ). The observed pattern is also consistent with the 238 overall mutation rate to compensation being smaller than that of global adaptation to 239 the gut. rpoB and rpoC were the two targets for compensation to Rif R , with deletions 240 in rpoB being alleles that have not been commonly detected in vitro. The three targets 241 for compensation to Str R : in the rpsE, rpsL and rpsD genes have been detected in 242 previous studies of compensation under laboratory conditions ( Fig. 4d-e and 243 Supplementary Table 5 ). 244
Overall these observations are consistent with the observed variation of fitness effects 245 of AR in the short-term competitions ( Fig. 1b) and with the results of the simple 246 theoretical model described above (Fig. 2-3) , predicting a strong personalized pattern 247 of compensation for deleterious pleiotropic mutations at the initial stages of evolution 248 ( Fig. 4) . 249
250

DISCUSSION 251
Many chromosomal encoded AR exhibit a fitness cost when growing in in vitro 252 artificial laboratory environments. How previously measured costs of AR in vitro 253 translate into the natural environments is currently poorly known. Yet, the 254 quantification of the strength of selection for and against resistance in ecosystems 255 such as the mammalian gut is critical for understanding the levels of the microbiota 256 resistome 8 . In the species rich intestinal tract, bacteria ferociously compete for 257 resources and the environment may not be as constant as that of laboratory settings. 258
Indeed, we have found that the costs of both single and double resistances in vitro 259 could significantly deviate from their estimated in vivo effects, even in the simplest 260 case of mono-colonized hosts ( Fig. 1b and Supplementary Fig. 3 ). In the more 261 relevant model of E. coli colonization of a complex gut microbiota with inter-species 262
interactions, we uncovered that the same AR mutation can have a wide range of 263 fitness effects in hosts that are genetically identical, eat the same diet and experience 264 the same environment. Following antibiotic treatment, a given AR mutation showed a 265 strong deleterious effect in competitive fitness within one host but increased in 266 frequency in another -a display of antagonistic pleiotropy. A similar finding occurs 267 when double resistant strains compete with single resistant lineages (Supplementary 268 Figure 2 ). Since the host specific effect is absent in germ-free mice (Fig. 1c) , our 269 observations suggest that selection against resistance is acting unequally across mice 270 due to the presence of the microbiota. In accordance with previous reports 48,49 , a 271 decrease in microbiota diversity following antibiotic treatment is also seen in our 272 study, as well as a high variance of its composition between mice ( Fig. 1e-f) . 273
Differences in the composition of the microbiota can lead to differences in metabolic 274 activity of the whole ecosystem, which in turn will likely result in distinct levels of 275 inter-species competition for the different gut resources. Since the AR studied here, 276
involving changes in the ribosome and RNA polymerase, affect metabolism 50-52 , it is 277 natural to expect that their fitness effects may depend on the microbiota composition, other key simplifications in the model, we also did not explicitly consider the 295 emergence of compensatory mutations nor the clonal interference pattern observed 296 during the long-term evolutionary dynamics of E. coli resistant strains in the gut. The 297 13 quantitative understanding of how globally adaptive mutations interfere with 298 background specific compensatory mutations during the eco-evolutionary dynamics 299 of gut commensal bacteria after microbiota dysbiosis is an important problem for 300 future theoretical work, that can illuminate specific in vivo experimental evolution 301
designs. 302
The findings that metabolic adaptations occur in every host, that typical compensatory 303 mutations may take a long time to reach high frequency, and that reversion to a 304 sensitive state are not detected, has consequences for the expansion and maintenance 305 of resistant strains within hosts. A recent study showing that a short-term cefuroxime 306 treatment can increase the general level of resistance in the human gut microbiota 57 , 307 corroborates this expectation, although the factorial level of potential causes for such 308 an effect is enormous when studying AR levels in humans. 309
The dysbiotic period following antibiotic treatment offers a time window of 310 opportunity for disease causing bacteria to invade the host intestine. The associated 311 possible reduction in costs of resistance at this critical period offers an important 312 breach for the maintenance of resistant pathogens, and further difficulties in 313 elimination of these agents. Yet in the case of AR mutations that affect nutritional 314 metabolism, an interesting possibility of using specific dietary supplementation could 315 be considered. As metabolic model predictions from genomic data of strains is rapidly 316 improving and specific carbon supplementations can sometimes be effective in 317 changing the frequency of specific strains 58 , hopes that such progress can be 318 harnessed to lower resistance levels may become within reach. 319
A study with a simplified model microbiota has shown that the presence of a single 320 gut bacterial species can change the outcome of intra-species competitions 59 . 321
Therefore, a plausible strategy to eliminate resistant pathogens is to find competitors 322 14 that will reliably and specifically generate a cost for the resistant strain. Studying the 323 fitness effects of resistance mutations in the presence of specific gut microbes or 324 defined collections of microbiota members, and further testing the efficiency of these 325 strains in dysbiosis models could lead to optimized approaches for selection against 326
resistance. 327
According to our model, multi-species can coexist when there are, at least, two 328 resources available for which the different species compete. Importantly, the species 329 are able to consume both resources, even though they have different abilities to 330 consume each one. There is evidence that several gut species can use more than one 331 carbon sugar 60 . Even though carbon-catabolite-repression (CCR) is known to occur in 332 E. coli for carbon sources such as glucose 61 , bacteria can find a multitude of 333 nutritional niches when colonizing the mammalian gut. Successful species probably 334 evolved to be versatile enough to switch their realized nutrient niche regularly or to 335 simultaneously utilize multiple substrates 62 . In agreement, the gene expression 336 profiles E. coli MG1655 grown in mucus (mimicking the gut nutritionally) identified 337 genes involved in catabolism of several sugars such as N-acetylglucosamine, sialic 338 acid, glucosamine, fucose, ribose, glucuronate, galacturonate, gluconate, and 339 maltose 63 . 340
We found evidence for significant antagonistic pleiotropy for AR fitness effects 341 between hosts. Antagonistic pleiotropy could also occur within a single host intestine, 342
as individual E. coli cells might experience different niches in such structured 343 environment, while the population as a whole may consume different carbon sources 344 simultaneously 58 . The simple theoretical model of resource competition helps 345 explaining how the host-dependent AR costs can arise from general properties of the 346 ecosystem even without species-specific or cross-feeding interactions. Pairwise cross-347 feeding interactions between gut bacteria can nevertheless occur 64,65 and higher order 348 cross-feeding interactions are thought to be involved in complex microbial 349 communities 66 . While cross-feeding interactions are a feature of the gut ecosystem, 350 these networks of metabolites produced by bacteria can also be affected by strong Recent studies that define the bacterial taxa within human microbiota demonstrate 355 significant variability between individuals 67,68 . One of these studies 68 was able to track 356 individuals from hundreds of people by using the microbiota data available in the 357 "Human Microbiome Project" database. This is strong evidence that our microbiota 358 has enough unique characteristics to be almost used as a "fingerprint" of an 359 individual. As the microbiota can affect the cost of resistance, it is likely that the fate 360 of resistant bacteria in humans is also host-specific. Therefore, depending on 361 individual microbiomes and resistomes, the fight against antibiotic resistance in the 362 current era might require personalized medicine. 363 364 METHODS 365
E. coli and mice strains 366
All of the strains were derived from Escherichia coli strain K-12 MG1655. Since the 367 gat operon was observed to be a mutation hotspot under strong selection for our 368 strains in the mouse gut 35,45 , we pre-adapted our E. coli strain to a gat negative 369 phenotype by knocking down the gatZ gene permanently. Briefly, P1 transductions 370 were performed in order to delete the gatZ gene from our strains as a pre-adaptive 371 mutation and strain E. coli JW2082-1 from the KEIO collection was used as a donor. 372
The new strains, LC88 and RB929 (ΔlacIZYA::scar galK::cat-YFP/CFP ∆gatZ::FRT-373 aph-FRT), were used as wild-type strains in the competitions. P1 transduction was 374 also used to insert the point mutation rpoB H526Y (Rif R ) in the wild-type background 375 and to pass the gatZ deletion from the wild-type strains to isogenic antibiotic resistant 376 strains, carrying either the point mutation rpsL K43T (Str R ) or both rpsL K43T Six-to-thirteen week-old female C57BL/6J germ-free (GF) mice were used as hosts 383
for the in vivo competitions in the absence of microbiota, while 6-to-8 week-old 384 female C57BL/6J specific pathogen free (SPF) mice were used for the in vivo 385 competitions and the evolution experiment in the presence of microbiota. GF mice 386 were bred and raised at the IGC gnotobiology facility in dedicated axenic isolators 387 (La Calhene/ORM).) Young adults were transferred into sterile ISOcages (Tecniplast) 388 before the competition experiments. 389 390
In vitro competitions 391
The strains were streaked from the frozen stocks into LB agar with antibiotics 392 corresponding to their resistance and incubated at 37°C for 24 hours, followed by 393 acclimatization for 24h in LB and in minimal media with 0.4% glucose, in 96-well 394 plates, at 37°C, with shaking (700 rpm). Each resistant strain was mixed in a 1:1 ratio 395 with the sensitive wild-type, and competitions were performed for 24h in the same 396 and reference strains, respectively. The gat negative phenotype had no interference in 411 between the negative epistasis in between resistances 9,22 . 412 413
In vivo competitions 414
To measure the fitness effects and to evolve the resistant strains in SPF mice, we used 415 a streptomycin treatment in order to break the colonization resistance. Mice were 416 separated into individual cages and given autoclaved drinking water containing 417 streptomycin sulfate (5g/L) for seven days and then mice were given regular 418 autoclaved drinking water for 2 days, in order to wash out the antibiotic from the gut 419 and allow for the microbiota stabilization. After 4 hours of starvation for food and 420 water, the mice were gavaged with 100 µl of a ≈10 9 cells/ml suspension with a 1:1 421 ratio of the two competing strains. 422
To make the suspension, the strains were streaked from stocks in LB agar with 423 antibiotics corresponding to their resistance two days before gavage and incubated for 424 24 hours, followed by an overnight culture of a single colony for each biological 425 replicate in BHI (brain heart infusion) media with the corresponding antibiotic. The 426 cultures were then diluted 100-fold and grown in BHI media until an OD 600nm ≈ 2. 427
Flow cytometry was used to assess the number of cells per growth and therefore 428 adjust the initial number of cells in order to prepare the suspension for the gavage. 429
The same protocol was used in order to generate the bacteria suspension for the GF 430 mice. Mice fecal pellets were collected 4 hours and every 24 after gavage, for 5 days, 
Microbiota analysis 442
To assess the gut microbiota composition of mice, we extracted DNA from fecal 443 samples from two experiments: the measurement of fitness costs in SPF mice (Fig. 1)  444 and from the compensatory evolution of the resistant strains (Fig. 4) . For the analysis 445 of the microbiota perturbation during the measurement of the fitness costs, fecal 446 samples were collected from 8 mice belonging to different litters, before the start of 447 the antibiotic treatment and 72 hours after its end, corresponding to the first time- To study the adaptation of resistance strains to the gut, three sister mice from 2 477 different litters were used, for a total of 6 mice. For each resistant genotype, we 478 colonized 1 mouse from each litter with a mix of YFP and CFP-labeled bacteria. The 479 whole colonization protocol was identical to the in vivo competitions as described for 480 the SPF mice. Samples were collected 24h after gavage and every 48h thereafter, until 481 39 days post colonization. All samples were stored in 15% glycerol at -80°C. NC_000913.3 as a reference, with the polymorphism option selected, and the 496 following parameters: (a) rejection of polymorphisms in homopolymers of a length 497 greater than three, (b) rejection of polymorphisms that are not present in at least three 498 reads in each strand, and (c) rejection of polymorphisms that do not have a p-value for 499 quality greater than 0.05,(d) rejection of polymorphisms with less than 3 of coverage 500 in each strand and (e) rejection of polymorphisms with less than 1% frequency. All 501
other Breseq parameters were used as default. Hits that were present in all of our 502 ancestral mutants as well as homopolymers were discarded. Hits that were likely to be 503 due to misalignment of repetitive regions were also discarded. Regarding the 504 downstream analysis, target genes that appeared only in one sample and had a 505 frequency lower than 5% were not considered. 
Where ! is the density of species , ! (!) is the consumption rate of substrate by 514 species , ! is the constant substrate supply, is the yield and is the microbial 515 death rate. A detailed description of the parameter choice and the algorithm is given 516 in the supplementary information. The implementation of the competitions and the 517 graphical resolution of the two-resource scenario were done in RStudio 1.1.463 and 518 the source code is available upon request to the authors. 519 520
Statistical analysis 521 22
The selection coefficient of the in vivo competitions was tested in R software, through 522 an F-statistic on a predictive linear model of the mutant/sensitive or double 523 mutant/single mutant ratio over time, generated through the observed ratio on sampled 524 time-points from 24, 48, 72, 96 and 120 hours after gavage. The null hypothesis is 525 that the slope, which is an estimation of the selection coefficient, is equal to 0. When 526 the null hypothesis was rejected, p-value < 0.05, the mutant was considered to have a 527 cost if the slope of the model was negative and to have a fitness benefit if the slope 528 was positive. F tests were performed to analyze the variance in between hosts. 529
Normality of each treatment was tested through with Shapiro Wilk test and normality 530 of the treatments involving competitions in the presence of microbiota was further 531 tested through Kolmogorov-Smirnov test. 
